St. Johns Investment Management Company LLC Sells 413 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

St. Johns Investment Management Company LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 13.5% during the 3rd quarter, HoldingsChannel.com reports. The fund owned 2,646 shares of the healthcare conglomerate’s stock after selling 413 shares during the period. St. Johns Investment Management Company LLC’s holdings in UnitedHealth Group were worth $1,547,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in UNH. International Assets Investment Management LLC boosted its holdings in UnitedHealth Group by 78,814.4% in the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock valued at $3,096,896,000 after acquiring an additional 5,290,025 shares during the last quarter. Swedbank AB bought a new position in shares of UnitedHealth Group during the 1st quarter worth approximately $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in shares of UnitedHealth Group by 107.8% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock worth $1,141,113,000 after buying an additional 1,196,758 shares in the last quarter. Lone Pine Capital LLC bought a new position in shares of UnitedHealth Group during the 2nd quarter worth approximately $480,903,000. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of UnitedHealth Group by 30.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after buying an additional 880,183 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Up 0.7 %

Shares of UnitedHealth Group stock opened at $564.56 on Friday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $608.63. The firm has a market cap of $521.33 billion, a PE ratio of 36.78, a P/E/G ratio of 1.67 and a beta of 0.58. The stock has a fifty day moving average price of $583.52 and a 200-day moving average price of $537.96. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same quarter last year, the firm posted $6.56 EPS. The firm’s revenue for the quarter was up 9.2% on a year-over-year basis. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.49%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Analysts Set New Price Targets

UNH has been the topic of a number of research analyst reports. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday. Robert W. Baird increased their target price on UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a report on Wednesday, July 17th. Truist Financial reiterated a “buy” rating and issued a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Finally, TD Cowen increased their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.